TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Allergan AS
Closing information (x1000 EUR)
| Closing information | 2019/12 | 2018/12 | 2017/12 |
| Turnover |
2,764
|
2,901
|
3,965 |
| Financial expenses |
7
|
3
|
3 |
| Earnings before taxes |
263
|
269
|
445 |
| Total assets |
1,892
|
1,622
|
1,687 |
| Current assets |
1,892
|
1,622
|
1,687 |
| Current liabilities |
473
|
422
|
671 |
| Equity capital |
1,418
|
1,201
|
1,016 |
| - share capital |
10
|
10
|
10 |
| Shareholders | 0 | 0 | 0 |
Financial ratios
| Fiscal year | 2019/12 | 2018/12 | 2017/12 |
| Solvency |
74.9%
|
74.0%
|
60.2% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
9.5%
|
9.3%
|
11.2% |
| Return on assets (ROA) |
14.3%
|
16.8%
|
26.6% |
| Current ratio |
400%
|
384.4%
|
251.4% |
| Return on equity (ROE) |
18.5%
|
22.4%
|
43.8% |
| Change turnover |
-185
|
-990
|
290 |
| Change turnover % |
-6%
|
-25%
|
8% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2019/12 | 2018/12 | 2017/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.